Female sex is strongly associated with cognitive impairment in HIV infection

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Neurological Sciences

• Publication date

  2020-09-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10072-020-04705-xPMID 32929628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between cognitive reserve and cognitive performance in people with HIV: a systematic review and meta-analysis

  2019cited by this paper
• HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy

  2019cited by this paper
• A Systematic Review of the Literature

  2019cited by this paper
• Defining Cognitive Reserve and Implications for Cognitive Aging

  2019cited by this paper
• Differences in Cognitive Function Between Women and Men With HIV

  2018cited by this paper
• Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing

  2018cited by this paper
• Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery

  2017cited by this paper
• HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

  2016cited by this paper
• Gender-Specific Degeneration of Dementia-Related Subcortical Structures Throughout the Lifespan

  2016cited by this paper
• Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals

  2016cited by this paper
• HIV- and AIDS-associated neurocognitive functioning in Zambia – a perspective based on differences between the genders

  2016cited by this paper
• Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention – A Comparison with Parkinson’s Disease

  2015cited by this paper
• Education and Risk of Dementia: Dose-Response Meta-Analysis of Prospective Cohort Studies

  2015cited by this paper
• Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.

  2015cited by this paper
• Surveillance for certain health behaviors among states and selected local areas--Behavioral Risk Factor Surveillance System, United States, 2011.

  2014cited by this paper
• Revised surveillance case definition for HIV infection--United States, 2014.

  2014cited by this paper
• Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

  2014cited by this paper
• Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria

  2014cited by this paper
• Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection

  2014cited by this paper
• Validity of the International HIV dementia scale in Brazil.

  2013cited by this paper
• Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature

  2013cited by this paper
• A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale

  2013cited by this paper
• HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy

  2010cited by this paper
• Comparison of scales to evaluate the progression of HIV-associated neurocognitive disorder.

  2010cited by this paper
• Updated research nosology for HIV-associated neurocognitive disorders

  2007cited by this paper
• Antiretroviral pharmacokinetic profile: a review of sex differences.

  2007cited by this paper
• The International HIV Dementia Scale: a new rapid screening test for HIV dementia

  2005cited by this paper
• Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

  1999cited by this paper

• Microglial reactivity and nodule formation are associated with Synaptodendritic damage in the brains of people with HIV-1.

  2025cites this paper
• Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Effects of acute cannabidiol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice

  2024cites this paper
• Effects of acute Δ9-tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice.

  2023cites this paper
• The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment

  2023cites this paper
• Alzheimer ’ s disease as a viral disease: Revisiting the infectious hypothesis ☆

  2023cites this paper
• Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms

  2022cites this paper
• The impacts of HIV infection, age, and education on functional brain networks in adults with HIV

  2022cites this paper
• Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases

  2021cites this paper